Volitionrx (VNRX) Operating Leases (2019 - 2025)

Volitionrx (VNRX) reported Operating Leases of $276558.0 for Q4 2025, down 56.27% on a YoY basis from $632441.0 in Q4 2024, and down 21.26% quarter-over-quarter from $351211.0 in Q3 2025.

Volitionrx (VNRX) Operating Leases (2019 - 2025) Analysis & Trends

Volitionrx has reported Operating Leases for 7 years, with the latest figure at $276558.0 in Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 56.27% year-over-year to $276558.0; the trailing twelve-month figure through Dec 2025 stood at $276558.0 (down 56.27% YoY), and the FY2025 full-year result was $276558.0, down 56.27% from the prior year.
  • Operating Leases for Q4 2025 stood at $276558.0, down from $351211.0 in the prior quarter.
  • The five-year high for Operating Leases was $843443.0 in Q1 2022, with the low at $143998.0 in Q3 2021.
  • Historically, Operating Leases has averaged $402495.6 across 5 years, with a median of $378054.0 in 2023.
  • Annual changes were most pronounced in 2022 — Operating Leases soared 358.39% — and 2025, when it tumbled 56.27%.
  • Volitionrx's Operating Leases stood at $217305.0 in 2021, then surged by 84.11% to $400091.0 in 2022, then declined by 5.51% to $378054.0 in 2023, then jumped by 67.29% to $632441.0 in 2024, then plunged by 56.27% to $276558.0 in 2025.
  • The last three Operating Leases figures came in at $276558.0 (Q4 2025), $351211.0 (Q3 2025), and $417015.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Volitionrx 53.00 Mn 50.54 Mn -1.01 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 276,558.00
Sep 30, 2025 351,211.00
Jun 30, 2025 417,015.00
Mar 31, 2025 369,342.00
Dec 31, 2024 632,441.00
Sep 30, 2024 448,045.00
Jun 30, 2024 350,810.00
Mar 31, 2024 396,376.00
Dec 31, 2023 378,054.00
Sep 30, 2023 323,957.00
Jun 30, 2023 340,314.00
Mar 31, 2023 381,722.00
Dec 31, 2022 400,091.00
Sep 30, 2022 449,326.00
Jun 30, 2022 761,323.00
Mar 31, 2022 843,443.00
Dec 31, 2021 217,305.00
Sep 30, 2021 143,998.00
Jun 30, 2021 166,085.00
Dec 31, 2020 179,624.00